Clinical Research Directory
Browse clinical research sites, groups, and studies.
Post-market Cosmetic Evaluation of Ariessence™ Pure PDGF+ Following Ablative Laser
Sponsor: Lynch Regenerative Medicine
Summary
ariessence is intended to be used as a viscous, leave-on solution designed for topical application to the face. It is intended to be used following non-medical cosmetic procedures, performed by licensed healthcare professionals to enhance comfort and maintain skin hydration. This study is designed to be a multi-center, post-market cosmetic evaluation of ariessence applied to the full face after an ablative laser procedure to evaluate improvements in procedure tolerability and improvements in the appearance of the skin, compared to an emollient control.
Official title: A Multi-center, Post-market Cosmetic Evaluation of Ariessence™ Pure PDGF+ Following Ablative Laser for the Tolerability and Improvement in the Appearance of Aging Skin.
Key Details
Gender
All
Age Range
40 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
21
Start Date
2026-04-16
Completion Date
2027-02
Last Updated
2026-07-21
Healthy Volunteers
No
Interventions
ariessence pure PDGF+™ is a sterile aqueous formulation containing Hyaluronic Acid and pure platelet-derived growth factor (PDGF).
To compare time to appearance-based recovery and subject satisfaction between ariessence and standard of care groups using standardized photographs and investigator/subject ratings for tolerability and satisfaction
Locations (2)
Laser & Skin Surgery Medical Group
Sacramento, California, United States
The Practice of Brian S. Biesman, MD
Nashville, Tennessee, United States